SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 32.31+1.4%Nov 26 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: aknahow who wrote (5423)1/29/1998 8:24:00 PM
From: Tharos  Read Replies (1) of 17367
 
George,
You make a great point that when Wall Street's "quarterly" mentality punishes a firm for good/normal business practices it is probably a good time to scoop up at bargin prices. If your outlook is longterm and the fundamentals haven't changed, then short term technical problems should be viewed as opportunity. Personally, I find R&D numbers important in my bio-tech Fundamental Analysis process. If I don't think the numbers are high enough, I don't invest. It is the R&D that develops the break-through product(s) from which we economically benefit as partial owners of the firm.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext